Related references
Note: Only part of the references are listed.Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma
Carsten Kobe et al.
BLOOD (2008)
Heart and coronary artery protection in patients with mediastinal Hodgkin lymphoma treated with intensity-modulated radiotherapy: Dose constraints to virtual volumes or to organs at risk?
Mithra Ghalibafian et al.
RADIOTHERAPY AND ONCOLOGY (2008)
Hodgkin's lymphoma: The role of radiation in the modern combined strategies of treatment
Richard T. Hoppe
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2007)
Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
Ranjana Advani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Randomized comparison of consolidation radiation versus observation in bulky Hodgkin's lymphoma with post-chemotherapy negative positron emission tomography scans
Marco Picardi et al.
LEUKEMIA & LYMPHOMA (2007)
Early interim 2-[18F]Fluoro-2-Deoxy-D-Glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin's lymphoma:: A report from a joint Italian-Danish study
Andrea Gallamini et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in lymphoma
Malik E. Juweid et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma
M Hutchings et al.
ANNALS OF ONCOLOGY (2005)
Early detection of relapse by whole-body positron emission tomography in the follow-up of patients with Hodgkin's disease
G Jerusalem et al.
ANNALS OF ONCOLOGY (2003)
The involved field is back: issues in delineating the radiation field in Hodgkin's disease
J Yahalom et al.
ANNALS OF ONCOLOGY (2002)
Prognostic value of positron emission tomography in the evaluation of post-treatment residual mass in patients with Hodgkin's disease and non-Hodgkin's lymphoma
R Naumann et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Thoracic positron emission tomography using 18F-fluorodeoxyglucose for the evaluation of residual mediastinal Hodgkin disease
MR Weihrauch et al.
BLOOD (2001)
Can positron emission tomography with [18F]-fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need additional therapy from others in whom additional therapy would mean avoidable toxicity?
K Spaepen et al.
BRITISH JOURNAL OF HAEMATOLOGY (2001)
Share Paper
